彭博社:孤星、阿尔塔里斯与One Rock竞购龙沙资产
Lone Star, Altaris, One Rock Said Among Bidders for Lonza Assets - Bloomberg.com
生物技术与制药领域的最新动态
Lone Star, Altaris, One Rock Said Among Bidders for Lonza Assets - Bloomberg.com
How Lonza Group AG (Common Stock) (LO3A) stock reacts to stronger dollar - Portfolio Risk Report & Free Long-Term Investment Growth Plans - newser.com
Lonza To Expand Bioscience Testing With Acquisition of Redberry - Technology Networks
Captain Lonza Henderson Jr. TUCSON NOW Interview - KOLD
Regulatory, cGMP, and CDMO Challenges: A CPHI Conversation with Lonza Capsugel, Part Two - PharmTech.com
Solving formulation challenges with Lonza’s advanced technologies - Nutraceutical Business Review
Lonza head of bioscience talks recent Redberry acquisition - BioProcess International
Lonza to expand bioscience testing offering with the acquisition of Redberry - SelectScience
Dosage Form Innovations: A CPHI Frankfurt Conversation with Lonza’s Frank Romanski, Part One - PharmTech.com
Can Mixed Fundamentals Have A Negative Impact on Lonza Group AG (VTX:LONN) Current Share Price Momentum? - Yahoo Finance
Q&A: Large-scale commercial expansion at Lonza’s Stein facility - Fierce Pharma
Lonza to buy rapid microbial testing firm Redberry SAS - Fierce Biotech
Bristol in Friendswood to break ground in coming months; Lonza plans renovation in Pearland - Community Impact | News
Lonza to Acquire Redberry SAS - Contract Pharma
Lonza to expand bioscience testing offering with the acquisition of Redberry - Drug Discovery News
Lonza confirms "long-term commercial supply agreement" at U.S. biologic drug site - Investing.com
Earnings call transcript: Lonza Group Q3 2025 sees strong CDMO growth - Investing.com
Lonza's recently purchased Calif. biologics site plays key role in sales rebound - Fierce Pharma
Lonza Reports Strong Q3 2025 and Confirms Full-Year Outlook - TipRanks
Lonza Delivers a Strong Q3 2025 and Confirms Full-Year 2025 Outlook for its CDMO and CHI Businesses - TradingView